October 25, 2007 - Terumo Interventional Systems announced at TCT 2007 the launch of the TR Band, a radial artery compression device designed to safely and comfortably stop bleeding after transradial procedures, designed to allow the clinician to easily check for clotting and to promote greater patient comfort.
October 24, 2007 – St. Jude Medical took the stage at TCT 2007 to introduce its new hybrid carotid guiding sheath ...
October 25, 2007 - GE Healthcare displayed its SnapShot Pulse technology designed to maintain high computed tomography ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 25, 2007 – Siemens highlighted at TCT 2007 the syngo DynaCT Cardiac solution, a planning tool that enables cross ...
October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.
October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...
October 23, 2007 - Hologic Inc.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...
October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...
October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.
October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix ...
October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...
October 24, 2007
